|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 370 for Abcb4

0.033s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1832122
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1876522
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Note: Expression was not detected in the immune system.
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1741222
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1754022
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3599822
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3280922
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1833322
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3287022
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1752522
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1821522
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3557722
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1702122
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1756322
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1668822
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757722
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757522
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1738322
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1802422
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1768022
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Note: Expression was not detected in the skull (base and vault).
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:4422989
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:2672022
Stage: TS22
Assay Id: MGI:5422084
Age: embryonic day 14.5
Note: Expression was not detected in whisker follicle.
Specimen Label: EB1729; Specimen B597
Detected: false
Specimen Num: 1
Publication
First Author: Raymond M
Year: 1989
Journal: Proc Natl Acad Sci U S A
Title: Mammalian multidrug-resistance gene: correlation of exon organization with structural domains and duplication of an ancestral gene.
Volume: 86
Issue: 17
Pages: 6488-92
Publication
First Author: Voshol PJ
Year: 2001
Journal: Biochem J
Title: Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine.
Volume: 356
Issue: Pt 2
Pages: 317-25
Publication
First Author: Thapa M
Year: 2020
Journal: J Immunol
Title: Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease.
Volume: 204
Issue: 12
Pages: 3117-3128
Publication
First Author: De Ponti A
Year: 2015
Journal: Int J Cancer
Title: Chronic liver inflammation and hepatocellular carcinogenesis are independent of S100A9.
Volume: 136
Issue: 10
Pages: 2458-63
Publication  
First Author: Schmithals C
Year: 2024
Journal: EBioMedicine
Title: Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.
Volume: 105
Pages: 105178
Publication
First Author: Meadows V
Year: 2023
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
Volume: 324
Issue: 1
Pages: G60-G77
Publication
First Author: Eckert C
Year: 2016
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Podoplanin discriminates distinct stromal cell populations and a novel progenitor subset in the liver.
Volume: 310
Issue: 1
Pages: G1-12
Publication
First Author: Li Z
Year: 2005
Journal: J Biol Chem
Title: Phosphatidylcholine homeostasis and liver failure.
Volume: 280
Issue: 45
Pages: 37798-802
Publication
First Author: Ella E
Year: 2014
Journal: Oncotarget
Title: Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.
Volume: 5
Issue: 21
Pages: 10318-31
Publication
First Author: Sokolović A
Year: 2012
Journal: Biochim Biophys Acta
Title: Overexpression of insulin like growth factor binding protein 5 reduces liver fibrosis in chronic cholangiopathy.
Volume: 1822
Issue: 6
Pages: 996-1003
Publication      
First Author: Fan W
Year: 2019
Journal: Gastroenterology
Title: ECM1 Prevents Activation of Transforming Growth Factor beta, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Publication
First Author: Wang R
Year: 2019
Journal: J Lipid Res
Title: Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice.
Volume: 60
Issue: 1
Pages: 85-97
Publication
First Author: Li Z
Year: 2011
Journal: Biochim Biophys Acta
Title: The role of phosphatidylethanolamine methyltransferase in a mouse model of intrahepatic cholestasis.
Volume: 1811
Issue: 4
Pages: 278-83
Publication
First Author: Kennedy L
Year: 2020
Journal: Lab Invest
Title: Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling.
Volume: 100
Issue: 6
Pages: 837-848
Publication
First Author: Li Z
Year: 2007
Journal: J Biol Chem
Title: Choline redistribution during adaptation to choline deprivation.
Volume: 282
Issue: 14
Pages: 10283-9
Publication
First Author: Li Z
Year: 2006
Journal: Cell Metab
Title: The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.
Volume: 3
Issue: 5
Pages: 321-31
Publication
First Author: Plösch T
Year: 2002
Journal: Hepatology
Title: Mdr P-glycoproteins are not essential for biliary excretion of the hydrophobic heme precursor protoporphyrin in a griseofulvin-induced mouse model of erythropoietic protoporphyria.
Volume: 35
Issue: 2
Pages: 299-306
Publication
First Author: van der Velde AE
Year: 2007
Journal: Gastroenterology
Title: Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice.
Volume: 133
Issue: 3
Pages: 967-75
Publication
First Author: Peng ZW
Year: 2017
Journal: Hepatol Commun
Title: The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis.
Volume: 1
Issue: 9
Pages: 957-972
Publication
First Author: Meadows V
Year: 2019
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2-/- mice.
Volume: 1865
Issue: 12
Pages: 165557
Publication
First Author: Potikha T
Year: 2013
Journal: Hepatology
Title: Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis.
Volume: 58
Issue: 1
Pages: 192-204
Publication
First Author: Fuchs CD
Year: 2022
Journal: Hepatol Commun
Title: Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2(-/-) mouse model of sclerosing cholangitis via immunomodulatory effects.
Volume: 6
Issue: 9
Pages: 2368-2378
Publication
First Author: Koopen NR
Year: 1999
Journal: J Hepatol
Title: Decreased Na+-dependent taurocholate uptake and low expression of the sinusoidal Na+-taurocholate cotransporting protein (Ntcp) in livers of mdr2 P-glycoprotein-deficient mice.
Volume: 30
Issue: 1
Pages: 14-21
Publication
First Author: Kotaka M
Year: 2008
Journal: Neurosci Res
Title: Identification of negative transcriptional factor E4BP4-binding site in the mouse circadian-regulated gene Mdr2.
Volume: 60
Issue: 3
Pages: 307-13
Publication
First Author: Ceci L
Year: 2020
Journal: Am J Pathol
Title: Knockout of the Tachykinin Receptor 1 in the Mdr2-/- (Abcb4-/-) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis.
Volume: 190
Issue: 11
Pages: 2251-2266
Publication
First Author: Modica S
Year: 2012
Journal: Gastroenterology
Title: Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Volume: 142
Issue: 2
Pages: 355-65.e1-4
Publication
First Author: Lanton T
Year: 2017
Journal: Hepatology
Title: Interleukin 6-dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitis.
Volume: 65
Issue: 5
Pages: 1600-1611
Publication  
First Author: Grand M
Year: 2020
Journal: Front Immunol
Title: Hepatic Inflammation Confers Protective Immunity Against Liver Stages of Malaria Parasite.
Volume: 11
Pages: 585502
Publication
First Author: Li R
Year: 2023
Journal: Int J Biol Sci
Title: Interaction between dual specificity phosphatase-1 and cullin-1 attenuates alcohol-related liver disease by restoring p62-mediated mitophagy.
Volume: 19
Issue: 6
Pages: 1831-1845
Publication
First Author: Rothweiler S
Year: 2019
Journal: Purinergic Signal
Title: Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis.
Volume: 15
Issue: 3
Pages: 375-385
Publication
First Author: Hefetz-Sela S
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation.
Volume: 111
Issue: 49
Pages: 17582-7
Publication
First Author: Yoshida S
Year: 2014
Journal: Gastroenterology
Title: Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
Volume: 147
Issue: 6
Pages: 1378-92
Publication
First Author: Petrescu AD
Year: 2020
Journal: Sci Rep
Title: Ghrelin reverses ductular reaction and hepatic fibrosis in a rodent model of cholestasis.
Volume: 10
Issue: 1
Pages: 16024
Publication
First Author: Sokolović A
Year: 2013
Journal: Biochim Biophys Acta
Title: Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(-/-) mice.
Volume: 1832
Issue: 6
Pages: 697-704
Publication
First Author: Ehlken H
Year: 2011
Journal: PLoS One
Title: Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure.
Volume: 6
Issue: 10
Pages: e25942
Publication
First Author: Mimche PN
Year: 2018
Journal: Sci Rep
Title: EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells.
Volume: 8
Issue: 1
Pages: 2532
Publication
First Author: Zhou T
Year: 2018
Journal: Lab Invest
Title: Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2-/- mice by diminishing senescence of cholangiocytes.
Volume: 98
Issue: 11
Pages: 1449-1464
Publication
First Author: Berkhout L
Year: 2019
Journal: Sci Rep
Title: Deletion of tumour necrosis factor α receptor 1 elicits an increased TH17 immune response in the chronically inflamed liver.
Volume: 9
Issue: 1
Pages: 4232
Publication
First Author: Mustacich DJ
Year: 1998
Journal: Arch Biochem Biophys
Title: Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice.
Volume: 350
Issue: 2
Pages: 183-92
Publication
First Author: McDaniel K
Year: 2017
Journal: Hepatology
Title: Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
Volume: 65
Issue: 2
Pages: 544-559
Publication
First Author: Kok T
Year: 2003
Journal: Gastroenterology
Title: Induction of hepatic ABC transporter expression is part of the PPARalpha-mediated fasting response in the mouse.
Volume: 124
Issue: 1
Pages: 160-71
Publication
First Author: Gros P
Year: 1986
Journal: Cell
Title: Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.
Volume: 47
Issue: 3
Pages: 371-80
Publication
First Author: Hsu SI
Year: 1989
Journal: J Biol Chem
Title: Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes.
Volume: 264
Issue: 20
Pages: 12053-62
Publication  
First Author: Nishio T
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.
Volume: 118
Issue: 29
Publication
First Author: Borst P
Year: 1996
Journal: Eur J Cancer
Title: What have we learnt thus far from mice with disrupted P-glycoprotein genes?
Volume: 32A
Issue: 6
Pages: 985-90
Publication
First Author: Stiedl P
Year: 2015
Journal: Hepatology
Title: Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.
Volume: 61
Issue: 2
Pages: 613-26
Publication
First Author: Patsenker E
Year: 2008
Journal: Gastroenterology
Title: Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Volume: 135
Issue: 2
Pages: 660-70
Publication
First Author: Eisenbraun MD
Year: 1999
Journal: J Immunol
Title: mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice.
Volume: 163
Issue: 5
Pages: 2621-7
Publication
First Author: Uhr M
Year: 2008
Journal: Neuron
Title: Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.
Volume: 57
Issue: 2
Pages: 203-9
Publication
First Author: Frijters CM
Year: 1999
Journal: J Lipid Res
Title: The role of different P-glycoproteins in hepatobiliary secretion of fluorescently labeled short-chain phospholipids.
Volume: 40
Issue: 11
Pages: 1950-8
Publication
First Author: Kunne C
Year: 2014
Journal: Lab Invest
Title: Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.
Volume: 94
Issue: 10
Pages: 1103-13
Publication
First Author: Sancho P
Year: 2012
Journal: PLoS One
Title: NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
Volume: 7
Issue: 9
Pages: e45285
Publication
First Author: Rawles LA
Year: 2007
Journal: Mol Reprod Dev
Title: The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting.
Volume: 74
Issue: 11
Pages: 1483-9
Publication
First Author: O'Hara SP
Year: 2019
Journal: J Biol Chem
Title: The transcription factor ETS1 promotes apoptosis resistance of senescent cholangiocytes by epigenetically up-regulating the apoptosis suppressor BCL2L1.
Volume: 294
Issue: 49
Pages: 18698-18713
Publication
First Author: Petrescu AD
Year: 2020
Journal: Am J Pathol
Title: Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.
Volume: 190
Issue: 3
Pages: 586-601
Publication
First Author: Barashi N
Year: 2013
Journal: Hepatology
Title: Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
Volume: 58
Issue: 3
Pages: 1021-30
Publication
First Author: Gros P
Year: 1986
Journal: Nature
Title: Isolation and expression of a complementary DNA that confers multidrug resistance.
Volume: 323
Issue: 6090
Pages: 728-31
Publication
First Author: Kirschner LS
Year: 1995
Journal: DNA Cell Biol
Title: Amplification of the murine mdr2 gene and a reconsideration of the structure of the murine mdr gene locus.
Volume: 14
Issue: 1
Pages: 47-59
Publication
First Author: Borst P
Year: 1997
Journal: Trends Genet
Title: Genetic dissection of the function of mammalian P-glycoproteins.
Volume: 13
Issue: 6
Pages: 217-22
Publication
First Author: Tang Y
Year: 1999
Journal: J Biol Chem
Title: Use of a peptide mimotope to guide the humanization of MRK-16, an anti-P-glycoprotein monoclonal antibody.
Volume: 274
Issue: 39
Pages: 27371-8
UniProt Feature
Begin: 1
Description: Phosphatidylcholine translocator ABCB4
Type: chain
End: 1276
Publication
First Author: Gadaleta RM
Year: 2018
Journal: Sci Rep
Title: Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis.
Volume: 8
Issue: 1
Pages: 17210
Publication
First Author: Chowdhury S
Year: 2013
Journal: World J Gastroenterol
Title: Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.
Volume: 19
Issue: 19
Pages: 2883-93
Publication
First Author: Chan IS
Year: 2012
Journal: Cancer Res
Title: Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma.
Volume: 72
Issue: 24
Pages: 6344-50
Publication
First Author: Jörs S
Year: 2015
Journal: J Clin Invest
Title: Lineage fate of ductular reactions in liver injury and carcinogenesis.
Volume: 125
Issue: 6
Pages: 2445-57
Publication
First Author: Zhou C
Year: 2023
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway.
Volume: 1870
Issue: 1
Pages: 166870
Publication
First Author: Dekkers DW
Year: 1998
Journal: Biochemistry
Title: Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1).
Volume: 37
Issue: 42
Pages: 14833-7
Publication
First Author: Smith AJ
Year: 1999
Journal: J Hepatol
Title: Liver gene disruptions: winners by KO?
Volume: 31
Issue: 4
Pages: 752-9
Publication
First Author: Dhir R
Year: 1990
Journal: Bull Cancer
Title: Structural and functional characterization of the mouse multidrug resistance gene family.
Volume: 77
Issue: 11
Pages: 1125-9
Publication
First Author: Chianale J
Year: 1995
Journal: Biochim Biophys Acta
Title: Differences between nuclear run-off and mRNA levels for multidrug resistance gene expression in the cephalocaudal axis of the mouse intestine.
Volume: 1264
Issue: 3
Pages: 369-76
Publication
First Author: Worthmann A
Year: 2017
Journal: Nat Med
Title: Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis.
Volume: 23
Issue: 7
Pages: 839-849
Publication  
First Author: Zhou M
Year: 2017
Journal: Nat Commun
Title: Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.
Volume: 8
Pages: 15433
Publication
First Author: Mair M
Year: 2010
Journal: Gastroenterology
Title: Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.
Volume: 138
Issue: 7
Pages: 2499-508
Publication
First Author: Umeshappa CS
Year: 2021
Journal: Cell Rep
Title: Liver-specific T regulatory type-1 cells program local neutrophils to suppress hepatic autoimmunity via CRAMP.
Volume: 34
Issue: 13
Pages: 108919
Publication
First Author: Karatayli E
Year: 2019
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Effect of alcohol on the interleukin 6-mediated inflammatory response in a new mouse model of acute-on-chronic liver injury.
Volume: 1865
Issue: 2
Pages: 298-307
Publication
First Author: Petty AJ
Year: 2019
Journal: J Clin Invest
Title: Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
Volume: 129
Issue: 12
Pages: 5151-5162
Publication
First Author: Caviglia JM
Year: 2018
Journal: Hepatology
Title: MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis.
Volume: 67
Issue: 6
Pages: 2414-2429
Publication
First Author: Hernandez C
Year: 2018
Journal: J Clin Invest
Title: HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.
Volume: 128
Issue: 6
Pages: 2436-2451
Publication
First Author: Teeter LD
Year: 1991
Journal: DNA Cell Biol
Title: Murine mdr-1, mdr-2, and mdr-3 gene expression: no coinduction with the Cyp1a-1 and Nmo-1 genes in liver by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Volume: 10
Issue: 6
Pages: 433-41
Publication
First Author: Sawicki WT
Year: 2006
Journal: Gene Expr Patterns
Title: Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development.
Volume: 6
Issue: 7
Pages: 738-46